Opioid Maker Purdue Pharma Files Bankruptcy Plan
TUESDAY, March 16, 2021 -- Purdue Pharma has filed a bankruptcy restructuring plan that seeks to end thousands of lawsuits over the role that its painkiller Oxycontin played in the U.S. opioid epidemic.
The plan requires members of the Sackler family to relinquish control of the company and remakes it into a new corporation with revenue targeted exclusively at reducing the nation's opioid crisis, The New York Times reported. There is also a pledge from the Sacklers to give $4.275 billion from their personal fortune -- $1.3 billion more than their original offer -- to states, municipalities, tribes, and other plaintiffs for costs associated with the opioid epidemic.
Payments could start being made to different groups of lawsuit plaintiffs if the plan is approved by a majority of the company's creditors and Judge Robert Drain of federal bankruptcy court in White Plains, New York, The Times reported. The largest of those groups includes state and local governments that have faced devastating costs due to the opioid epidemic. Others include individual plaintiffs such as families whose relatives overdosed or guardians of infants born with neonatal abstinence syndrome; hospitals and insurers; and tribes.
However, it is not clear if the plan will be accepted because dozens of states and the District of Columbia have said the bankruptcy process would prevent them from direct legal action against individual members of the Sackler family whose contributions are insufficient, The Times reported.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
MONDAY, April 5, 2021 -- Annual medical costs associated with substance use disorder (SUD) in U.S. emergency departments and inpatient settings exceeded $13 billion in 2017,...
FRIDAY, April 2, 2021 -- There have been recent increases in overdose deaths involving both cocaine and opioids and involving both psychostimulants and opioids, according to an...
FRIDAY, April 2, 2021 -- An increased risk for nonfatal drug-related poisoning is associated with benzodiazepine treatment in patients with opioid use disorder, according to a...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.